Marianna Carrabotta

Bologna, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Talazoparib engages innate immune activation via PARP trapping-dependent cGAS/STING activation in Ewing Sarcoma.

Talazoparib engages innate immune activation via PARP trapping-dependent cGAS/STING activation in Ewing Sarcoma.

Journal: Cancer letters
Published: January 21, 2026

Targeting metastasis in paediatric bone sarcomas.

Targeting metastasis in paediatric bone sarcomas.

Journal: Molecular cancer
Published: March 11, 2025

Genomic profiling of a collection of patient-derived xenografts and cell lines identified ixabepilone as an active drug against chemo-resistant osteosarcoma.

Genomic profiling of a collection of patient-derived xenografts and cell lines identified ixabepilone as an active drug against chemo-resistant osteosarcoma.

Journal: Journal of experimental & clinical cancer research : CR
Published: January 29, 2025

EphA2 in Cancer: Molecular Complexity and Therapeutic Opportunities.

EphA2 in Cancer: Molecular Complexity and Therapeutic Opportunities.

Journal: International journal of molecular sciences
Published: October 08, 2024

Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages.

Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages.

Journal: Cancer immunology research
Published: May 26, 2023

CIC-Rearranged Sarcomas: An Intriguing Entity That May Lead the Way to the Comprehension of More Common Cancers.

CIC-Rearranged Sarcomas: An Intriguing Entity That May Lead the Way to the Comprehension of More Common Cancers.

Journal: Cancers
Published: September 22, 2022

Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma.

Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma.

Journal: Cancer research
Published: April 20, 2021

ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity.

ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity.

Journal: Journal of experimental & clinical cancer research : CR
Published: September 23, 2019

Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations.

Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations.

Journal: Scientific reports
Published: February 17, 2019
Showing 1-9 of 9

Last Updated: 09/26/2026